This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Sarah Miller smiller@biohealthinnovation.org
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
Come join us for a virtual event with Dr. Laundette Jones. Dr. Jones is currently an Associate Professor at the University of Maryland School of Medicine and serves in several leadership roles, including being the Co-Director of the Program in Health Equity and Population Health and Associate Director of the STAR-PREP (Postbaccalaureate Research and Education Program).
UPDATE
Mother Nature had other plans for our original date! Due to rain in the forecast we’ve postponed Oktoberfest to October 26th at Brookeville Beer Farm.
We’re sad we won’t get to see you on the original date but we’re still excited to share some brews, some pizza and great company at CRB’s glorious return to Oktoberfest.
If you’ve already registered, good on you. If you haven’t, the rain gave you a reprieve so register below today!
This is our favorite annual event that has been sponsored by CRB for the past 8 years. Join us at Brookeville Beer Farm, just outside of Olney, MD. If you haven’t been – the venue is picturesque and it’s always a great crowd. It’s outdoors and the beers and pizza are renowned. Arrive early to have a drink on us and enjoy free pizza while it lasts.
Inventors and startup founders are invited to attend a webinar panel series offered by Johns Hopkins Technology Ventures (JHTV). This series was developed to help inventors and founders avoid blind spots and learn best practices for launching and scaling successful startups.
Join Women In Bio-Capital Region Frederick MAPS group for a morning of golf, outdoor therapy, and networking. Enjoy a group lesson with the Steve Bosdosh Golf Academy's pros as they break down all aspects of the game, including full swing techniques, short game tips, and putting. Afterward, we'll enjoy drinks and a luncheon.
Don't hesitate, REGISTER now! The golf session is limited to 25 participants. All levels are welcome in our always energetic and friendly atmosphere. If you prefer networking over golf, there is an option to register only for the networking/lunch portion.
A burgeoning cell and gene therapy sector coupled with a world-leading vaccine industry has the Maryland life science hub brimming with bioprocessing and manufacturing activity and innovation. Advanced biomanufacturing is booming in Maryland & industry leaders like Kite, NextCure, TCR2, Emergent, GSK, Lonza & Catalent are creating thousands of new biomanufacturing jobs and opportunities to expand your career.
Come out for this new Monthly happy hour event to expand your network and meet other industry professionals from around the area. Enjoy a free beer and connect about what’s happening in the ecosystem.
Event Details:
Location: True Respite Brewing Company
Date: Nov 2nd
Time: 5-7pm
*each month we will have open networking followed by a short topical discussion
Johns Hopkins innovators are invited to meet with Richard Hughen, CEO of Linshom and FastForward Mentor-in-Residence to discuss market assessments, commercialization, and funding for medical devices.
Johns Hopkins faculty and startup leaders will gain insight from Hughen’s experience working with Fortune 500 companies in the medical device industry in addition to creating and exiting two of his own startups. Office hour sessions provide entrepreneurs the opportunity to discuss how to:
Host
Joseph Conrad
Dr. Swaroop and his team developed a NEW gene therapy treatment for a dominant form of LCA, that counteracts dominant mutations in the CRX gene. More specifically, correct CRX gene sequence packaged in an AAV vector was tested in retinal organoids derived from affected patients, resulting in partial recovery of proper photoreceptor development. Please note that even partial recovery of photoreceptors should help regain useful vision in patients. This new technology shows promise as a viable treatment for a currently untreatable rare disease condition.
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Sarah Miller smiller@biohealthinnovation.org
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
dsThe Society of Physician Entrepreneurs (SoPE) is pleased to announce that Christopher Kersey, M.D., will join us in a fireside chat on November 17 at Noon ET.
Moderator: Jeffrey N. Hausfeld MD, MBA
Co-Founder and Chairman of SoPE
Chairman and Chief Medical Officer BioFactura, Inc.
President, Memory Care Communities, LLC
Christopher Kersey, founding managing partner of healthcare-focused Havencrest Capital Management, closed a $356 million fund earlier this year, and will discuss how the macroeconomic environment we are facing will affect the private equity industry. What does it mean to SoPE members and the startup community if holding periods for PE firms are going to start to lengthen again? What is the best strategy if your startup may be susceptible to discretionary spending or government shutdowns?
Can PE firms help their portfolio companies deal with issues of wage and raw materials inflation, as well as supply chain disruption? According to Chris Kersey, “There’s $1 trillion dollars of private-equity dry powder on the sidelines,” he said. “This is available but uncommitted capital that will continue to drive transaction volume for the foreseeable future. Private-equity fund managers are incented to deploy capital regardless of the macroeconomic situation.” Join the SoPE fireside chat and learn how!